# Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

> **NCT00290823** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 110 (estimated)

## Conditions studied

- Neurocysticercosis

## Interventions

- **DRUG:** Albendazole
- **DRUG:** Dexamethasone
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT00290823
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290823, "Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00290823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*